PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 166 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 3.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $228,000 | +1100.0% | 12,675 | +1482.4% | 0.01% | +350.0% |
| Q4 2019 | $19,000 | -54.8% | 801 | -49.0% | 0.00% | -33.3% |
| Q3 2019 | $42,000 | +162.5% | 1,571 | +249.9% | 0.00% | +200.0% |
| Q1 2019 | $16,000 | +700.0% | 449 | +498.7% | 0.00% | – |
| Q3 2018 | $2,000 | -60.0% | 75 | -48.3% | 0.00% | – |
| Q1 2018 | $5,000 | -97.1% | 145 | -95.5% | 0.00% | -100.0% |
| Q3 2017 | $174,000 | +2800.0% | 3,223 | +3029.1% | 0.01% | +1300.0% |
| Q2 2017 | $6,000 | +50.0% | 103 | +3.0% | 0.00% | – |
| Q1 2017 | $4,000 | -93.8% | 100 | -96.5% | 0.00% | -100.0% |
| Q4 2016 | $65,000 | +51.2% | 2,889 | +54.7% | 0.01% | +75.0% |
| Q3 2016 | $43,000 | +377.8% | 1,868 | +367.0% | 0.00% | +300.0% |
| Q2 2016 | $9,000 | -30.8% | 400 | +56.2% | 0.00% | -50.0% |
| Q4 2015 | $13,000 | -75.0% | 256 | -77.5% | 0.00% | -60.0% |
| Q2 2015 | $52,000 | -50.9% | 1,140 | -59.0% | 0.01% | -61.5% |
| Q1 2015 | $106,000 | +715.4% | 2,780 | +509.6% | 0.01% | +550.0% |
| Q2 2014 | $13,000 | +8.3% | 456 | -1.1% | 0.00% | 0.0% |
| Q1 2014 | $12,000 | -86.8% | 461 | -86.9% | 0.00% | -86.7% |
| Q4 2013 | $91,000 | +23.0% | 3,528 | +27.1% | 0.02% | +87.5% |
| Q3 2013 | $74,000 | +27.6% | 2,775 | +17.7% | 0.01% | +60.0% |
| Q2 2013 | $58,000 | – | 2,357 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |